Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein - Wikidata - awgldk - TriplyDB

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein

http://www.wikidata.org/entity/Q36718966

about

Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders A two-stage meta-analysis identifies several new loci for Parkinson's disease Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function Bidirectional integrative regulation of Cav1.2 calcium channel by microRNA miR-103: role in pain MicroRNA let-7: an emerging next-generation cancer therapeutic microRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T cells MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders miR2Disease: a manually curated database for microRNA deregulation in human disease Epigenetic principles and mechanisms underlying nervous system functions in health and disease Potential Role of Epigenetic Mechanism in Manganese Induced Neurotoxicity MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases The involvement of microRNAs in neurodegenerative diseases Neuronal dark matter: the emerging role of microRNAs in neurodegeneration Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalities Novel microRNAs differentially expressed during aging in the mouse brain Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review FGF receptors: cancer biology and therapeutics MicroRNAs in Neurotoxicity Next generation tools for the annotation of human SNPs Repression of alpha-synuclein expression and toxicity by microRNA-7.Quantitative assessment of the effect of FGF20 rs12720208 variant on the risk of Parkinson's disease: a meta-analysis.MicroSNiPer: a web tool for prediction of SNP effects on putative microRNA targets Systematic analysis of microRNA targeting impacted by small insertions and deletions in human genome.Genome-wide analysis of natural selection on human cis-elements Autism Genetic Database (AGD): a comprehensive database including autism susceptibility gene-CNVs integrated with known noncoding RNAs and fragile sites.Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates SNPs in microRNA target sites and their potential role in human disease MicroRNAs in Experimental Models of Movement Disorders.SNPs in microRNA binding sites as prognostic and predictive cancer biomarkers A novel statistic for genome-wide interaction analysis Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96.MicroRNA polymorphisms: a giant leap towards personalized medicine.Variants in SNCA Gene Are Associated with Parkinson's Disease Risk and Cognitive Symptoms in a Brazilian Sample.The AVPR1A gene and substance use disorders: association, replication, and functional evidence.FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease.MicroRNAs targeting Nicastrin regulate Aβ production and are affected by target site polymorphisms Neuroprotection of microRNA in neurological disorders (Review)Understanding microRNAs in neurodegeneration.

P2860

Q21129476-A37C44FA-F950-4C84-B4AB-72693714F8ED Q21144948-1F1832BF-A751-4F66-8CAC-1AB62D33141D Q21202833-91DFE5FB-B622-42EF-8333-B3B1E65818CF Q24594587-C7802DCE-B085-4564-A090-D07FEF59A678 Q24644251-71F4A0EB-28DF-4933-8D05-E835DBBEB1D3 Q24648506-09EA1467-EC27-4BAC-A4E4-08DFDC5BA59C Q24652987-8FA58158-8FB3-47C6-9BE8-366AF064A7B5 Q24655615-6A9A0A12-2AFE-4F77-9853-7CCE4996AD5F Q24657549-CACDD858-63AE-4367-9708-15F6355DBDC3 Q26744563-82361D7E-A388-4AA3-B9D1-70DA1A365F51 Q26744819-1AADA356-5A40-4BC9-BA87-8BAEEC70A0F6 Q26858788-3B2A9C66-41B0-4F9D-AF61-9C815B412936 Q26859224-0342A227-AFCE-4797-B84F-3F37F2111027 Q27023811-0E875055-5452-40EA-BEB7-BDC138FF83DA Q27335905-110AF9EC-870A-4675-9F94-C06EDA052A01 Q28080047-32E53028-97D5-4972-8A08-1F2AD211E3BD Q28291186-569AB6A6-2B63-47F4-B3EB-5DB9DAD9AF2D Q28382954-B152A8D9-A9BE-493B-B210-B3515C0C3D92 Q28755491-C6489250-748F-4799-A106-9DE0103DCAA2 Q29542272-6DD21181-17B8-48CD-800A-6E976D24FA30 Q30238475-AA7E0949-C520-4469-B118-C7C875124F65 Q30429953-667F3ED5-DC75-44C9-A038-FD053E327F0A Q31104377-EC216150-524D-4BF8-A903-7F17567C82A2 Q33368053-FBB2C5FE-636E-4041-8A7A-096953EB765E Q33506546-458A28A5-5603-47F4-95EC-A45A1D6E2164 Q33567669-691B9F5A-7341-464B-855C-B91ABD40887E Q33601105-68A6FC35-069D-4633-9397-6D81C2C31AC0 Q33628856-12645720-63B0-42A6-B565-86D808EF5E97 Q33636313-24C642AE-26D8-4AF1-9A97-0985099A3AD1 Q33640984-7EBBB90D-B52A-4A51-8C4C-0C0F1092DE06 Q33707414-F5EB968E-EE18-449A-82A4-C9A1DE0BB580 Q33738316-3E546B85-D5E5-4D20-93C9-1ECC5449F851 Q33812664-D1ED954E-8BE9-43DB-B3AA-6C09439A8092 Q33813336-19FAC75F-114E-4684-A7CE-581FF09EF321 Q33852455-890F99FA-0A8C-48E4-9933-AFF185A7003B Q33873286-3071F925-0E7B-440B-B257-A1EEA8DE651A Q33906476-A4CB1C14-2AF2-4473-812D-511546581E58 Q33920169-F185C145-BFCB-4835-8E3C-C1B813A771F3 Q33932509-044D2694-3246-4DDF-91AD-8155AF58545A Q33995527-B20C5981-B3C4-4BA7-AFE2-6D5DDDD4434F

P2860

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein

http://www.wikidata.org/entity/Q36718966

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Variation in the miRNA-433 bin ...... rexpression of alpha-synuclein

@ast

Variation in the miRNA-433 bin ...... rexpression of alpha-synuclein

@en

type

label

Variation in the miRNA-433 bin ...... rexpression of alpha-synuclein

@ast

Variation in the miRNA-433 bin ...... rexpression of alpha-synuclein

@en

prefLabel

Variation in the miRNA-433 bin ...... rexpression of alpha-synuclein

@ast

Variation in the miRNA-433 bin ...... rexpression of alpha-synuclein

@en

P1433

Q36718966-AA300857-9FCA-4F97-A9E2-71CF07388DD2

P1476

Q36718966-F77FFD78-969B-4ED6-A552-0A84A03FDE0B

P2093

Q36718966-071C5C34-F30B-4108-B47C-759C6E831338

Q36718966-2E6F5D5B-D4DD-40A5-8284-13A6A88514CA

Q36718966-6091A5FB-F1AA-4EDA-A45C-28E2F4A4F049

Q36718966-88ECE3B6-B899-4F66-98D0-AEE2EB1400EB

Q36718966-CE942BE1-150E-4A32-9AB7-E7605A54E5EC

P2860

Q36718966-0BBCB6F1-DBCF-4AB2-87DA-717E0A0C9BC1

Q36718966-1D974053-14FB-478B-AF07-41F171EF95B9

Q36718966-1DB2EB01-999E-4F8F-B327-30AEDF880A38

Q36718966-2369348B-D927-4B66-9B92-AA75E970143D

Q36718966-26031A33-845C-48D4-836E-94166A974B23

Q36718966-295ECC95-0C5E-4859-9D5E-89911F43DAB5

Q36718966-30801E56-1B5C-4A62-8BB3-66476549AE34

Q36718966-4C41D732-A18C-4FFC-B173-7DAC60C27BEB

Q36718966-52906478-A324-4D03-A9CE-23CA8EC1B4E2

Q36718966-560B04B1-04D6-4CC7-A008-69CC0D8A2E4E

P304

Q36718966-E2B165E3-B52B-47C8-862E-D3780308C5BD

P31

Q36718966-D7FE3CA7-727A-488F-856D-736A67F2D42D

P356

Q36718966-E079AE17-82FB-466E-884F-EB1C952320DD

P407

Q36718966-BCAE3ADA-7558-46BC-8694-7D9F62926F41

P433

Q36718966-C0D89E7F-6BE9-4CF4-9E3E-9ACCB112F92E

P478

Q36718966-B99EC565-7EBB-464F-BCF1-B68455E011E2

P50

Q36718966-0DE69C5E-A7E1-4E74-B766-EB67F4A290DC

Q36718966-9F0686EA-F796-4936-80A1-5177CAF98120

Q36718966-EAAA214B-5EE6-46FE-9B12-7E6632782933

P577

Q36718966-5F796C22-43A9-4963-AE04-CEEAC71E7107

P5875

Q36718966-0CDA8547-3419-4415-8B0D-D9888977D7F0

P698

Q36718966-E44AC038-A6FB-4686-9089-0B9AC8F32886

P921

Q36718966-06961372-CD1F-4710-805F-3F3ADC805FE5

Q36718966-37B10CF3-D7EE-44C7-811C-F0393BD42332

Q36718966-5DE03A81-8629-4916-965A-679A91244C0E

P932

Q36718966-0E1982D2-536D-43EB-8D73-51D2D9DFC935

P356

J.AJHG.2007.09.021

P1433

American Journal of Human Genetics

P1476

Variation in the miRNA-433 bin ...... rexpression of alpha-synuclein

@en

P2093

Eden R Martin

http://www.w3.org/2001/XMLSchema#string

Gaofeng Wang

http://www.w3.org/2001/XMLSchema#string

Gregory Mayhew

http://www.w3.org/2001/XMLSchema#string

Joelle M van der Walt

http://www.w3.org/2001/XMLSchema#string

William K Scott

http://www.w3.org/2001/XMLSchema#string

P2860

Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation

High-resolution whole-genome association study of Parkinson disease.

Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

alpha-Synuclein locus triplication causes Parkinson's disease

Alpha-synuclein in Lewy bodies

A specific survival response in dopamine neurons at most risk in Parkinson's disease

A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep

Sequence variants in SLITRK1 are associated with Tourette's syndrome

Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons

P304

283-289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJHG.2007.09.021

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P50

Jeffery M. Vance

Stephan Züchner

P577

2008-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5600477

http://www.w3.org/2001/XMLSchema#string

P698

18252210

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2427225

http://www.w3.org/2001/XMLSchema#string